These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 14693724

  • 1. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.
    Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW.
    Diabetes; 2004 Jan; 53(1):250-64. PubMed ID: 14693724
    [Abstract] [Full Text] [Related]

  • 2. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.
    Steffes MW, Sibley S, Jackson M, Thomas W.
    Diabetes Care; 2003 Mar; 26(3):832-6. PubMed ID: 12610045
    [Abstract] [Full Text] [Related]

  • 3. Markers of beta cell function in type 1 diabetes mellitus.
    Vendrame F, Zappaterreno A, Dotta F.
    Minerva Med; 2004 Apr; 95(2):79-84. PubMed ID: 15272242
    [Abstract] [Full Text] [Related]

  • 4. Residual C-peptide in type 1 diabetes: what do we really know?
    VanBuecken DE, Greenbaum CJ.
    Pediatr Diabetes; 2014 Mar; 15(2):84-90. PubMed ID: 24645775
    [Abstract] [Full Text] [Related]

  • 5. Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes.
    Latres E, Greenbaum CJ, Oyaski ML, Dayan CM, Colhoun HM, Lachin JM, Skyler JS, Rickels MR, Ahmed ST, Dutta S, Herold KC, Marinac M.
    Diabetes; 2024 Jun 01; 73(6):823-833. PubMed ID: 38349844
    [Abstract] [Full Text] [Related]

  • 6. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
    Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliott JF, Bigam D, Kneteman NM, Warnock GL, Larsen I, Shapiro AM.
    Diabetes; 2001 Apr 01; 50(4):710-9. PubMed ID: 11289033
    [Abstract] [Full Text] [Related]

  • 7. Challenges in developing endpoints for type 1 diabetes intervention studies.
    Cernea S, Raz I, Herold KC, Hirshberg B, Roep BO, Schatz DA, Fleming GA, Pozzilli P, Little R, Schloot NC, Leslie RD, Skyler JS, Palmer JP, D-Cure Workshop.
    Diabetes Metab Res Rev; 2009 Nov 01; 25(8):694-704. PubMed ID: 19771545
    [Abstract] [Full Text] [Related]

  • 8. Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft.
    Keymeulen B, Gillard P, Mathieu C, Movahedi B, Maleux G, Delvaux G, Ysebaert D, Roep B, Vandemeulebroucke E, Marichal M, In 't Veld P, Bogdani M, Hendrieckx C, Gorus F, Ling Z, van Rood J, Pipeleers D.
    Proc Natl Acad Sci U S A; 2006 Nov 14; 103(46):17444-9. PubMed ID: 17090674
    [Abstract] [Full Text] [Related]

  • 9. Five-year follow-up after clinical islet transplantation.
    Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM.
    Diabetes; 2005 Jul 14; 54(7):2060-9. PubMed ID: 15983207
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients.
    Covic AM, Schelling JR, Constantiner M, Iyengar SK, Sedor JR.
    Kidney Int; 2000 Oct 14; 58(4):1742-50. PubMed ID: 11012908
    [Abstract] [Full Text] [Related]

  • 16. Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.
    Medina A, Parween S, Ullsten S, Vishnu N, Siu YT, Quach M, Bennet H, Balhuizen A, Åkesson L, Wierup N, Carlsson PO, Ahlgren U, Lernmark Å, Fex M.
    Diabetologia; 2018 Apr 14; 61(4):896-905. PubMed ID: 29209740
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. C-peptide used in the estimation of islet beta-cell function in diabetes.
    Gjessing HJ.
    Dan Med Bull; 1992 Oct 14; 39(5):438-52. PubMed ID: 1424818
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.